<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Garcia-Lopez MA</submitter><funding>Ministerio de Ciencia e Innovación (MCIN)</funding><funding>Fundación BBVA</funding><funding>Comunidad de Madrid</funding><funding>Ministerio de Ciencia e Innovación</funding><funding>Fundación BBVA (FBBVA)</funding><funding>Comunidad de Madrid (Community of Madrid)</funding><pagination>e2300096121</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10801893</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>121(3)</volume><pubmed_abstract>The prevalence of overweight and obesity continues to rise in the population worldwide. Because it is an important predisposing factor for cancer, cardiovascular diseases, diabetes mellitus, and COVID-19, obesity reduces life expectancy. Adipose tissue (AT), the main fat storage organ with endocrine capacity, plays fundamental roles in systemic metabolism and obesity-related diseases. Dysfunctional AT can induce excess or reduced body fat (lipodystrophy). &lt;i>Dido1&lt;/i> is a marker gene for stemness; gene-targeting experiments compromised several functions ranging from cell division to embryonic stem cell differentiation, both in vivo and in vitro. We report that mutant mice lacking the DIDO N terminus show a lean phenotype. This consists of reduced AT and hypolipidemia, even when mice are f</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>DIDO is necessary for the adipogenesis that promotes diet-induced obesity.</pubmed_title><pmcid>PMC10801893</pmcid><funding_grant_id>S2017/BMD-3804</funding_grant_id><funding_grant_id>PID2022-142616OB-100</funding_grant_id><funding_grant_id>&amp;quot;The role of Dido...&amp;quot;</funding_grant_id><funding_grant_id>PID2019-110574RB-100</funding_grant_id><funding_grant_id>"The role of Dido..."</funding_grant_id><pubmed_authors>Sabio G</pubmed_authors><pubmed_authors>Fischer T</pubmed_authors><pubmed_authors>Mora A</pubmed_authors><pubmed_authors>Sanchez de Diego A</pubmed_authors><pubmed_authors>Talavera Gutierrez A</pubmed_authors><pubmed_authors>Garcia-Lopez MA</pubmed_authors><pubmed_authors>Medina-Gomez G</pubmed_authors><pubmed_authors>Pons T</pubmed_authors><pubmed_authors>Martinez-A C</pubmed_authors><pubmed_authors>Corrales P</pubmed_authors><pubmed_authors>van Wely KHM</pubmed_authors></additional><is_claimable>false</is_claimable><name>DIDO is necessary for the adipogenesis that promotes diet-induced obesity.</name><description>The prevalence of overweight and obesity continues to rise in the population worldwide. Because it is an important predisposing factor for cancer, cardiovascular diseases, diabetes mellitus, and COVID-19, obesity reduces life expectancy. Adipose tissue (AT), the main fat storage organ with endocrine capacity, plays fundamental roles in systemic metabolism and obesity-related diseases. Dysfunctional AT can induce excess or reduced body fat (lipodystrophy). &lt;i>Dido1&lt;/i> is a marker gene for stemness; gene-targeting experiments compromised several functions ranging from cell division to embryonic stem cell differentiation, both in vivo and in vitro. We report that mutant mice lacking the DIDO N terminus show a lean phenotype. This consists of reduced AT and hypolipidemia, even when mice are f</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jan</publication><modification>2026-07-15T05:14:47.169Z</modification><creation>2025-04-04T11:24:42.732Z</creation></dates><accession>S-EPMC10801893</accession><cross_references><pubmed>38194457</pubmed><doi>10.1073/pnas.2300096121</doi></cross_references></HashMap>